rss
Ann Rheum Dis 2007;66:121-123 doi:10.1136/ard.2006.057331
  • Concise report

Up regulation of monocyte chemoattractant protein-1 expression in anti-citrulline antibody and immunoglobulin M rheumatoid factor positive subjects precedes onset of inflammatory response and development of overt rheumatoid arthritis

  1. S Rantapää-Dahlqvist1,
  2. K Boman2,
  3. A Tarkowski3,
  4. G Hallmans1
  1. 1Departments of Rheumatology and Nutritional Research, Umeå University, Umeå, Sweden
  2. 2Department of Medicine, Skellefteå Hospital, Skellefteå, Sweden
  3. 3Department of Rheumatology and Inflammation Research, Göteborg University, Göteborg, Sweden
  1. Correspondence to:
    S Rantapää-Dahlqvist
    Department of Rheumatology, University Hospital, SE-901 85 Umeå, Sweden; Solbritt.Rantapaa.Dahlqvist{at}medicin.umu.se
  • Accepted 19 May 2006
  • Published Online First 1 June 2006

Abstract

Objective: To analyse the inflammatory mediators, including monocyte chemoattractant protein-1 (MCP-1), in blood samples donated years before onset of rheumatoid arthritis. Previously, it has been shown in these individuals that antibodies against cyclic citrullinated peptide (anti-CCP) detectable years before the onset of symptoms have a high predictive value for development of rheumatoid arthritis.

Methods: A nested case–control study was performed: patients with rheumatoid arthritis were identified from among blood donors antedating onset by a median of three years (pre-patients, n = 92); four matched controls were selected randomly for each pre-patient. Plasma were analysed for secretory phospholipase A2 (sPLA2) and MCP-1 using ELISA, for high-sensitivity C reactive protein (hsCRP) using the chemiluminescence method and for interleukin-6 using a sensitive bioassay.

Results: When the results were stratified for the presence of anti-CCP antibodies and immunoglobulin M-rheumatoid factor (IgM-RF), only MCP-1 levels were found to be significantly raised in patients with anti-CCP and IgM-RF compared with controls.

Conclusion: Levels of MCP-1 were significantly increased in the plasma of patients having anti-CCP antibodies or IgM-RF and who later developed rheumatoid arthritis. These findings indicate up regulation of chemotactic activity for leucocytes before the development of rheumatoid arthritis.

Footnotes

  • Funding: This study was supported by grants from the Swedish Research Council (K2003-74XD-14705-01), King Gustaf V’s 80-Year Fund, the Swedish Rheumatism Association, and the Medical Faculty of Umeå University, Umeå, Sweden.

  • Competing interests: None declared.

  • Published Online First 1 June 2006

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. All versions of this article:
    1. ard.2006.057331v1
    2. 66/1/121 most recent

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.